Morgan Stanley Raises Palantir Price Target to $155

Analyst: Sanjit Singh 1 min read Reproduced verbatim
Rating
Equalweight
Target
$155
from $98 (+58%)
Outcome
Reached
on September 3, 2025
Morgan Stanley and Palantir logos

What the analyst said

Morgan Stanley analyst Sanjit Singh raised the price target on Palantir Technologies Inc.

(NASDAQ: PLTR) to $155 (from $98) while maintaining an Equalweight rating.

“Palantir Has the Winning Recipe to Deploy AI. Wow… is our reaction to Q2 results with nearly every headline metric and KPI accelerating versus Q1 which itself was a very strong quarter.

As Gen AI has captured the collective mindset of tech and society at large over the last few years, it now seems as little coincidence that Palantir has just reported 8 straight quarters of accelerating YoY growth.

To contextualize how impressive the results from Q2 truly are, we agree with CEO Alex Karp’s suggestion to look at the “Rule of 40” which sums revenue growth and operating margin.

This came in at an astounding 94% in Q2 (up from 83% in Q1) consisting of +48% YoY revenue growth and 46% operating margin for a business that has just eclipsed $4 billion scale on a run-rate basis.

The real insight software investors are after is why Palantir has been uniquely able to deliver such best-inclass results.

It is increasingly clear that the recipe for such success lies in the company’s world class capabilities in: 1) software defined data integration/ingestion, 2) creating an ontology that allows AI models to have a true understanding of the underlying inter-relationships between data, transactions, employees and customers, 3) workflow automation and grounding state of the art models in enterprise data using the AIP platform and 4) bringing to bear highly technical engineers to help get customer’s complex use cases into production environments.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

PLTR trades at $175. The 17 analysts who set a target in the last 3 months range from $130 to $265, with a median of $250. This $155 target is 38% below the median.

Since the note PLTR has moved +9% (from $161). The 12-month window closed on August 5, 2026.

Track record

This call✓ Target reached on September 3, 2025, 29 days after the note.

Firm track recordMorgan Stanley: 81% of its 48 targets at least a year old were reached within 12 months (#9 of 26 firms); on Palantir, 3 of 6. Accuracy ranking →

Morgan Stanley on Palantir

Morgan Stanley price targets on Palantir

8 calls from January 6, 2025 to November 3, 2026. The target went from $60 to $233 (+288%). The rating moved from Sell to Hold.

Morgan Stanley targetPLTR share price
  1. November 3, 2026Target raised from $205 (+14%)Hold$233
  2. November 4, 2025Target raised from $155 (+32%)Hold$205
  3. August 5, 2025 This noteTarget raised from $98 (+58%)Hold$155
  4. May 6, 2025Target raised from $90 (+9%)Hold$98
  5. April 16, 2025Downgraded to Hold, target cut from $115 (−22%)Hold$90
  6. February 25, 2025Upgraded to Buy, target raised from $95 (+21%)Buy$115
  7. February 4, 2025Upgraded to Hold, target raised from $60 (+58%)Hold$95
  8. January 6, 2025Earliest call shownSell$60
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.